Search Results

You are looking at 1 - 10 of 122 items for :

  • medullary thyroid cancer x
Clear All
M. Schlumberger Department of Nuclear Medicine and Endocrine Oncology, Institute Gustave-Roussy and University Paris Sud, Villejuif, France

Search for other papers by M. Schlumberger in
Google Scholar
PubMed
Close
,
L. Bastholt Department of Oncology, Odense University Hospital, Odense, Denmark

Search for other papers by L. Bastholt in
Google Scholar
PubMed
Close
,
H. Dralle Department of Surgery, Martin Luther University, Halle-Wittenberg Medical Faculty, Halle/Saale, Germany

Search for other papers by H. Dralle in
Google Scholar
PubMed
Close
,
B. Jarzab MSC Memorial Cancer Center and Institute of Oncology, Gliwice, Poland

Search for other papers by B. Jarzab in
Google Scholar
PubMed
Close
,
F. Pacini Department of Endocrinologia, University of Siena, Siena, Italy

Search for other papers by F. Pacini in
Google Scholar
PubMed
Close
, and
J.W.A. Smit Department of Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands

Search for other papers by J.W.A. Smit in
Google Scholar
PubMed
Close

Methods of Development of Evidence-Based Guidelines The European Thyroid Association (ETA) Executive Committee launched a taskforce to produce guidelines on the treatment of metastatic medullary thyroid cancer (MTC). A chairperson was selected

Free access
Camille Buffet Department of Thyroid Pathologies and Endocrine Tumors, AP-HP, Pitié-Salpêtrière Hospital, Groupe de Recherche Clinique n°16 Tumeurs Thyroïdiennes, Sorbonne Université, Paris, France
UMR9019, Genome Integrity and Cancers, CNRS, Villejuif, France

Search for other papers by Camille Buffet in
Google Scholar
PubMed
Close
,
Sophie Leboulleux Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institut, Villejuif, France

Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Close
,
Françoise Kraeber-Bodéré Nuclear Medicine Department, Université de Nantes, CHU de Nantes, CNRS, Inserm, CRCINA, Nantes, France
CHU Nantes/ICO, Saint-Herblain, France

Search for other papers by Françoise Kraeber-Bodéré in
Google Scholar
PubMed
Close
,
Caroline Bodet-Milin Nuclear Medicine Department, Université de Nantes, CHU de Nantes, CNRS, Inserm, CRCINA, Nantes, France
CHU Nantes/ICO, Saint-Herblain, France

Search for other papers by Caroline Bodet-Milin in
Google Scholar
PubMed
Close
,
Laure Cabanes Department of Cardiology, APHP, Cochin Hospital, Paris, France
Université de Paris, Paris, France

Search for other papers by Laure Cabanes in
Google Scholar
PubMed
Close
,
Anthony Dohan Radiology Department, Université de Paris, Paris, France
Department of Radiology, AP-HP, Hôpital Cochin, Paris, France

Search for other papers by Anthony Dohan in
Google Scholar
PubMed
Close
,
Pascal Leprince Department of Thoracic and Cardiovascular Surgery, Sorbonne Université, AP-HP, Pitié-Salpêtrière Hospital, Paris, France

Search for other papers by Pascal Leprince in
Google Scholar
PubMed
Close
,
Martin Schlumberger UMR9019, Genome Integrity and Cancers, CNRS, Villejuif, France
Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institute, Villejuif, France

Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Close
,
Olivier Huillard Université de Paris, Sorbonne Paris Cité, Paris, France
Department of Medical Oncology, AP-HP, Hôpital Cochin, Paris, France

Search for other papers by Olivier Huillard in
Google Scholar
PubMed
Close
, and
Lionel Groussin INSERM Unité 1016, CNRS UMR 8104, Institut Cochin, Paris, France
Université de Paris, Paris, France
Department of Endocrinology, AP-HP, Hôpital Cochin, Paris, France

Search for other papers by Lionel Groussin in
Google Scholar
PubMed
Close

from medullary thyroid cancers (MTC) are uncommon. Their frequency in large autopsy series in patients with thyroid cancers is low, between 0 and 5% [ 1 - 5 ]. Given the rarity of this metastatic location, the outcome remains unclear. The average length

Open access
R. Elisei Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy

Search for other papers by R. Elisei in
Google Scholar
PubMed
Close
,
M. Alevizaki Endocrine Unit, Department of Medical Therapeutics, Athens University School of Medicine, Athens, Greece

Search for other papers by M. Alevizaki in
Google Scholar
PubMed
Close
,
B. Conte-Devolx Department of Endocrinology, La Timone Hospital, Aix Marseille University, Marseille, France

Search for other papers by B. Conte-Devolx in
Google Scholar
PubMed
Close
,
K. Frank-Raue Endocrine Practice, Molecular Laboratory, Heidelberg, Germany

Search for other papers by K. Frank-Raue in
Google Scholar
PubMed
Close
,
V. Leite Department of Endocrinology, Portuguese Institute of Oncology and CEDOC, Faculty of Medical Sciences, Lisbon, Portugal

Search for other papers by V. Leite in
Google Scholar
PubMed
Close
, and
G.R. Williams Molecular Endocrinology Group, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK

Search for other papers by G.R. Williams in
Google Scholar
PubMed
Close

Introduction Several guidelines have already been published on the diagnosis, management, and treatment of medullary thyroid cancer (MTC) [ 1 , 2 , 3 , 4 ], but there are no guidelines devoted specifically to RET genetic screening in

Free access
Laura Moss Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, United Kingdom

Search for other papers by Laura Moss in
Google Scholar
PubMed
Close
,
Catrin Cox Centre for Trials Research, Cardiff University, Cardiff, United Kingdom

Search for other papers by Catrin Cox in
Google Scholar
PubMed
Close
,
Jonathan Wadsley Weston Park Cancer Centre, Sheffield, United Kingdom

Search for other papers by Jonathan Wadsley in
Google Scholar
PubMed
Close
,
Kate Newbold The Royal Marsden NHS Foundation Trust, London, United Kingdom

Search for other papers by Kate Newbold in
Google Scholar
PubMed
Close
,
Mark W.J. Strachan Western General Hospital, Edinburgh, United Kingdom

Search for other papers by Mark W.J. Strachan in
Google Scholar
PubMed
Close
,
Maralyn Druce Barts and the London School of Medicine and Dentistry, London, United Kingdom

Search for other papers by Maralyn Druce in
Google Scholar
PubMed
Close
,
Neil Tolley Imperial College Healthcare NHS Trust, London, United Kingdom

Search for other papers by Neil Tolley in
Google Scholar
PubMed
Close
,
Kathryn Graham Beatson Oncology Centre, Glasgow, United Kingdom

Search for other papers by Kathryn Graham in
Google Scholar
PubMed
Close
,
Sarah Jefferies Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

Search for other papers by Sarah Jefferies in
Google Scholar
PubMed
Close
,
Lydia Fresco University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

Search for other papers by Lydia Fresco in
Google Scholar
PubMed
Close
,
Suganya Sivabalasingham University College Hospital NHS Foundation Trust, London, United Kingdom

Search for other papers by Suganya Sivabalasingham in
Google Scholar
PubMed
Close
,
Alistair Balfour East Kent Hospitals University NHS Foundation Trust, Canterbury, United Kingdom

Search for other papers by Alistair Balfour in
Google Scholar
PubMed
Close
, and
Chris Hurt Centre for Trials Research, Cardiff University, Cardiff, United Kingdom

Search for other papers by Chris Hurt in
Google Scholar
PubMed
Close

Introduction Medullary thyroid cancer (MTC) is a rare variant of thyroid cancer with different aetiology, presentation, treatment and symptoms compared to the more common differentiated thyroid cancers (DTC). Based on Cancer Research UK (CRUK

Free access
Simona Censi Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy

Search for other papers by Simona Censi in
Google Scholar
PubMed
Close
,
Jacopo Manso Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy

Search for other papers by Jacopo Manso in
Google Scholar
PubMed
Close
,
Teresa Benvenuti Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy

Search for other papers by Teresa Benvenuti in
Google Scholar
PubMed
Close
,
Ilaria Piva Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy

Search for other papers by Ilaria Piva in
Google Scholar
PubMed
Close
,
Maurizio Iacobone Endocrine Surgery Unit, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padua, Padua, Italy

Search for other papers by Maurizio Iacobone in
Google Scholar
PubMed
Close
,
Alberto Mondin Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy

Search for other papers by Alberto Mondin in
Google Scholar
PubMed
Close
,
Francesca Torresan Endocrine Surgery Unit, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padua, Padua, Italy

Search for other papers by Francesca Torresan in
Google Scholar
PubMed
Close
,
Daniela Basso Laboratory Medicine, Department of Medicine (DIMED), University of Padua, Padua, Italy

Search for other papers by Daniela Basso in
Google Scholar
PubMed
Close
,
Gino Crivellari Hereditary Tumor Unit, Istituto Oncologico Veneto, IOV - Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padova, Italy

Search for other papers by Gino Crivellari in
Google Scholar
PubMed
Close
,
Stefania Zovato Hereditary Tumor Unit, Istituto Oncologico Veneto, IOV - Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padova, Italy

Search for other papers by Stefania Zovato in
Google Scholar
PubMed
Close
, and
Caterina Mian Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy

Search for other papers by Caterina Mian in
Google Scholar
PubMed
Close

Introduction Medullary thyroid cancer (MTC) originates from parafollicular C-cells and represents 2% of all thyroid malignancies and 0.4–1.4% of all thyroid nodules ( 1 ). MTC is sporadic in 75–80% of cases or manifests as a hereditary tumor

Open access
Lars Bastholt Department of Oncology R, Odense University Hospital, Odense, Denmark

Search for other papers by Lars Bastholt in
Google Scholar
PubMed
Close
,
Michael C. Kreissl Department of Nuclear Medicine, Augsburg Hospital, Augsburg
Department of Nuclear Medicine, University Hospital Würzburg, Würzburg

Search for other papers by Michael C. Kreissl in
Google Scholar
PubMed
Close
,
Dagmar Führer Department of Endocrinology and Metabolism, University Hospital Essen, Essen, Germany

Search for other papers by Dagmar Führer in
Google Scholar
PubMed
Close
,
Ana L. Maia Serviço de Endocrinologia, Hospital de Clínicas de Porto Alegre, Porto Alegre

Search for other papers by Ana L. Maia in
Google Scholar
PubMed
Close
,
Laura D. Locati Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan

Search for other papers by Laura D. Locati in
Google Scholar
PubMed
Close
,
Léa Maciel Hospital das Clínicas de Ribeirăo Preto, Ribeirăo Preto, Brazil

Search for other papers by Léa Maciel in
Google Scholar
PubMed
Close
,
Yi Wu Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China

Search for other papers by Yi Wu in
Google Scholar
PubMed
Close
,
Kevin N. Heller AstraZeneca, Gaithersburg, Md., USA

Search for other papers by Kevin N. Heller in
Google Scholar
PubMed
Close
,
Alan Webster AstraZeneca, Macclesfield, UK

Search for other papers by Alan Webster in
Google Scholar
PubMed
Close
, and
Rossella Elisei Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Close

Introduction Medullary thyroid cancer (MTC) is a malignancy of the parafollicular C cells of the thyroid gland, and it accounts for an estimated 4% of thyroid cancers [ 1 , 2 ]. MTC can only be cured by surgery and, until recently, the

Free access
Luciana Puleo Endocrine Unit, Department of Clinical and Experimental Medicine

Search for other papers by Luciana Puleo in
Google Scholar
PubMed
Close
,
Laura Agate Endocrine Unit, Department of Clinical and Experimental Medicine

Search for other papers by Laura Agate in
Google Scholar
PubMed
Close
,
Irene Bargellini Department of Vascular and Interventional Radiology

Search for other papers by Irene Bargellini in
Google Scholar
PubMed
Close
,
Giuseppe Boni Regional Center of Nuclear Medicine

Search for other papers by Giuseppe Boni in
Google Scholar
PubMed
Close
,
Paolo Piaggi Endocrine Unit, Department of Clinical and Experimental Medicine

Search for other papers by Paolo Piaggi in
Google Scholar
PubMed
Close
,
Claudio Traino Regional Center of Nuclear Medicine

Search for other papers by Claudio Traino in
Google Scholar
PubMed
Close
,
Tommaso Depalo Regional Center of Nuclear Medicine

Search for other papers by Tommaso Depalo in
Google Scholar
PubMed
Close
,
Giulia Lorenzoni Department of Vascular and Interventional Radiology

Search for other papers by Giulia Lorenzoni in
Google Scholar
PubMed
Close
,
Francesca Bianchi Regional Center of Nuclear Medicine

Search for other papers by Francesca Bianchi in
Google Scholar
PubMed
Close
,
Duccio Volterrani Regional Center of Nuclear Medicine

Search for other papers by Duccio Volterrani in
Google Scholar
PubMed
Close
,
Sandra Brogioni Endocrine Unit, Department of Clinical and Experimental Medicine

Search for other papers by Sandra Brogioni in
Google Scholar
PubMed
Close
,
Valeria Bottici Endocrine Unit, Department of Clinical and Experimental Medicine

Search for other papers by Valeria Bottici in
Google Scholar
PubMed
Close
,
Maurizia Rossana Brunetto Hepatology Unit, University of Pisa, Pisa, Italy

Search for other papers by Maurizia Rossana Brunetto in
Google Scholar
PubMed
Close
,
Barbara Coco Hepatology Unit, University of Pisa, Pisa, Italy

Search for other papers by Barbara Coco in
Google Scholar
PubMed
Close
,
Eleonora Molinaro Endocrine Unit, Department of Clinical and Experimental Medicine

Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Close
, and
Rossella Elisei Endocrine Unit, Department of Clinical and Experimental Medicine

Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Close

Introduction Medullary thyroid cancer (MTC) is a neuroendocrine tumor arising from parafollicular or calcitonin-producing C cells that retain the biochemical and pathological features of the cells from which it derives. MTC accounts for 3

Open access
Grace Segall Eli Lilly and Company, Indianapolis, IN, USA

Search for other papers by Grace Segall in
Google Scholar
PubMed
Close
,
Ravinder Singh Eli Lilly and Company, Indianapolis, IN, USA

Search for other papers by Ravinder Singh in
Google Scholar
PubMed
Close
,
Min-Hua Jen Eli Lilly and Company, Indianapolis, IN, USA

Search for other papers by Min-Hua Jen in
Google Scholar
PubMed
Close
,
Isaac Sanderson Adelphi Real World, Bollington, UK

Search for other papers by Isaac Sanderson in
Google Scholar
PubMed
Close
,
Alex Rider Adelphi Real World, Bollington, UK

Search for other papers by Alex Rider in
Google Scholar
PubMed
Close
,
Katie Lewis Adelphi Real World, Bollington, UK

Search for other papers by Katie Lewis in
Google Scholar
PubMed
Close
, and
Urpo Kiiskinen Eli Lilly and Company, Indianapolis, IN, USA

Search for other papers by Urpo Kiiskinen in
Google Scholar
PubMed
Close

Introduction Medullary thyroid cancer (MTC) is a rare neuroendocrine tumour derived from calcitonin-secreting parafollicular C cells ( 1 ) and accounts for approximately 2‒4% of thyroid cancers ( 2 , 3 , 4 , 5 ) but up to 15% of thyroid-cancer

Open access
Cléber P. Camacho Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo

Search for other papers by Cléber P. Camacho in
Google Scholar
PubMed
Close
,
Susan C. Lindsey Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo

Search for other papers by Susan C. Lindsey in
Google Scholar
PubMed
Close
,
Teresa S. Kasamatsu Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo

Search for other papers by Teresa S. Kasamatsu in
Google Scholar
PubMed
Close
,
Alberto L. Machado Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Fleury Medicine and Health, São Paulo, Brazil

Search for other papers by Alberto L. Machado in
Google Scholar
PubMed
Close
,
João Roberto M. Martins Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo

Search for other papers by João Roberto M. Martins in
Google Scholar
PubMed
Close
,
Rosa Paula M. Biscolla Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Fleury Medicine and Health, São Paulo, Brazil

Search for other papers by Rosa Paula M. Biscolla in
Google Scholar
PubMed
Close
,
Magnus R. Dias da Silva Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo

Search for other papers by Magnus R. Dias da Silva in
Google Scholar
PubMed
Close
,
José Gilberto H. Vieira Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Fleury Medicine and Health, São Paulo, Brazil

Search for other papers by José Gilberto H. Vieira in
Google Scholar
PubMed
Close
, and
Rui M.B. Maciel Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Fleury Medicine and Health, São Paulo, Brazil

Search for other papers by Rui M.B. Maciel in
Google Scholar
PubMed
Close

Introduction Serum calcitonin (sCT) is a useful biomarker for medullary thyroid cancer (MTC) and is employed for its diagnosis and follow-up monitoring [ 1 ]. In addition, some guidelines advocate sCT measurements for the differential

Free access
Ségolène Hescot Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France

Search for other papers by Ségolène Hescot in
Google Scholar
PubMed
Close
,
Julien Masliah-Planchon Department of Genetics, Institut Curie, Paris, France

Search for other papers by Julien Masliah-Planchon in
Google Scholar
PubMed
Close
,
Pauline du Rusquec Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France

Search for other papers by Pauline du Rusquec in
Google Scholar
PubMed
Close
,
Célia Dupain Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France

Search for other papers by Célia Dupain in
Google Scholar
PubMed
Close
,
Maud Kamal Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France

Search for other papers by Maud Kamal in
Google Scholar
PubMed
Close
,
Vincent Servois Department of Radiology, Institut Curie, Paris, France

Search for other papers by Vincent Servois in
Google Scholar
PubMed
Close
, and
Ivan Bieche Department of Genetics, Institut Curie, Paris, France

Search for other papers by Ivan Bieche in
Google Scholar
PubMed
Close

.1016/S2213-8587(2100120-0 ) 7 Hedayati M Zarif Yeganeh M Sheikholeslami S Afsari F . Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer . Critical Reviews in Clinical Laboratory Sciences

Open access